DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Diovan (Valsartan) - C-Reactive Protein Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with C-Reactive Protein Increased ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Diovan (Valsartan) where reactions include c-reactive protein increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Diovan side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Skin Exfoliation, Urticaria, Pyrexia, Erythema, Human Herpes Virus 6 Serology Positive, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Oedema, Blood Glucose Increased, Blister, White Blood Cell Count Increased, Blood Alkaline Phosphatase Increased, Rash Generalised, Cytomegalovirus Test Positive, Blood Lactate Dehydrogenase Increased, Lymphocyte Stimulation Test Positive, Drug Rash With Eosinophilia and Systemic Symptoms, Pigmentation Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tegretol
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-08-07
    End date: 2007-08-27

Diovan
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-07-22
    End date: 2007-08-27

Ludiomil
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-08-15
    End date: 2007-08-27

Lipitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2007-08-26
    End date: 2007-08-27

PL Gran.
    Dosage: 3 g/ day
    Administration route: Oral
    Start date: 2007-08-28
    End date: 2007-08-29

Mexitil
    Dosage: 300 mg, daily
    Administration route: Oral
    Indication: Nerve Injury
    Start date: 2007-07-20
    End date: 2007-08-27

PL Gran.
    Dosage: 3 mg
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 2007-08-22
    End date: 2007-08-24

Metformin HCL
    Dosage: 500 mg, daily
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-08-10
    End date: 2007-08-27

Other drugs received by patient: Humalog; Humacart-N; Zantac



Possible Diovan side effects in 77 year old male

Reported by a physician from Japan on 2012-06-04

Patient: 77 year old male

Reactions: Lymphocyte Count Increased, C-Reactive Protein Increased, Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diovan

Other drugs received by patient: Fulpen; Bisoprolol Fumarate



Possible Diovan side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Gout, Diabetic Foot, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Albumin Urine Present, Hypertensive Crisis, Creatinine Urine Increased, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Aspirin; Pantoprazole; Other Antihypertensives; Simvastatin; Nebivolol HCL; Humalog; Simvastatin; Metformin HCL; Insulin Human; Adenuric; Diuretics



Possible Diovan side effects in male

Reported by a physician from Germany on 2012-05-14

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Albumin Urine Present, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan HCT
    Dosage: 160/12.5 mg per day
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Other drugs received by patient: Diuretics; Insulin Human; Adenuric; Nebivolol HCL; Simvastatin; Aspirin; Humalog; Pantoprazole; Metformin HCL; Other Antihypertensives; Simvastatin



Possible Diovan side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Dyspnoea, Refractory Anaemia, Angina Pectoris, Gout, Diabetic Foot, Impaired Work Ability, Left Ventricular Hypertrophy, Myelodysplastic Syndrome, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Carmen
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Other drugs received by patient: Diuretics; Other Antihypertensives; Nebivolol HCL; Aspirin; Simvastatin; Pantoprazole; Metformin HCL; Insulin Human; Adenuric; Humalog; Simvastatin



Possible Diovan side effects in male

Reported by a physician from Germany on 2012-05-04

Patient: male, weighing 130.0 kg (286.0 pounds)

Reactions: Refractory Anaemia, Dyspnoea, Diabetic Foot, Gout, Angina Pectoris, Impaired Work Ability, Myelodysplastic Syndrome, Left Ventricular Hypertrophy, Hypertensive Crisis, C-Reactive Protein Increased, Electrocardiogram QRS Complex Prolonged, Creatinine Urine Increased, Blood Pressure Diastolic Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Diovan HCT
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Hypertension

Diovan
    Dosage: 160 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20
    End date: 2009-03-19

Rasilez
    Dosage: 300 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-11-14
    End date: 2012-02-15

Valsartan
    Dosage: 320 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Torsemide
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-14

Doxazosin Mesylate
    Dosage: 8 mg, daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-27

Lercanidipine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-04-20

Diovan
    Dosage: 320 mg,daily
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2011-01-10

Other drugs received by patient: Humalog; Adenuric; Metformin HCL; Simvastatin; Insulin Human; Simvastatin; Pantoprazole; Diuretics; Aspirin; Nebivolol HCL; Other Antihypertensives



Possible Diovan side effects in female

Reported by a physician from Germany on 2012-01-24

Patient: female

Reactions: C-Reactive Protein Increased, Haematuria, Antiphospholipid Antibodies Positive, Systemic Lupus Erythematosus, RED Blood Cell Sedimentation Rate Increased

Drug(s) suspected as cause:
Diovan

Other drugs received by patient: Metoprolol Tartrate; Amlodipine

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012